What is the average price of valsartan exports from India?

The average unit price for valsartan exports from India is $8.45 USD per unit, with prices ranging from $0.01 to $4257.90 depending on formulation, packaging, and order volume. The total market is valued at $196.9M across 6,098 shipments.

Which ports handle valsartan exports from India?

The primary ports for valsartan exports from India are SAHAR AIR (15.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (10.3% of shipments), DELHI AIR (8.5% of shipments), NHAVA SHEVA SEA (INNSA1) (7.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Why is India a leading exporter of valsartan?

India is one of the world's leading exporters of valsartan due to its large base of 259 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports valsartan to 119 countries, demonstrating 61% global market coverage.

What certifications do Indian valsartan exporters need?

Indian valsartan exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

How many buyers import valsartan from India?

There are 663 registered buyers importing valsartan from India, spread across 119 countries. The repeat buyer rate is 72.2%, indicating strong long-term trade relationships and consistent product quality.

What is the market share of the top valsartan supplier from India?

MYLAN LABORATORIES LIMITED is the leading valsartan exporter from India with a market share of 37.1% and total export value of $73.0M across 578 shipments. The top 5 suppliers together control 75.5% of total export value.

Valsartan

India Pharmaceutical Trade Intelligence

$196.9M259 Suppliers119 CountriesHS 30049079

ExportsIndia → UNITED STATES60.8%India → GERMANY6.2%

ImportsITALY → India$280.6B BULGARIA → India$7.2M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Valsartan Export Data from India (2026) — Suppliers, Buyers & Trade Stats | TransData Nexus | TransData Nexus

How India Exports Valsartan to the World

Q: Who are the top valsartan exporters from India?

The top valsartan exporters from India are: 1. MYLAN LABORATORIES LIMITED — $73.0M (37.1% market share); 2. MACLEODS PHARMACEUTICALS LTD — $45.3M (23.0% market share); 3. SANDOZ PRIVATE LIMITED — $11.1M (5.6% market share); 4. ALEMBIC PHARMACEUTICALS LIMITED — $10.5M (5.3% market share); 5. DR.REDDY'S LABORATORIES LTD — $8.8M (4.5% market share). Together they account for 75.5% of India's total valsartan export value.

Q: What is the total export value of valsartan from India?

The total export value of valsartan from India is $196.9M USD, recorded across 6,098 shipment transactions from 259 active exporters to 119 destination countries. The average shipment value is $32.3K.

Q: Which countries import valsartan from India?

India exports valsartan to 119 countries worldwide. The top importing countries are: UNITED STATES (60.8% share, $119.8M), GERMANY (6.2% share, $12.3M), SLOVENIA (4.9% share, $9.6M), HUNGARY (3.6% share, $7.1M), IRAQ (3.4% share, $6.7M). These five markets account for 78.9% of total export value.

Q: What is the HS code for valsartan exports from India?

The primary HS code for valsartan exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Between 2022 and 2026, India exported $196.9M worth of valsartan across 6,098 verified shipments to 119 countries — covering 61% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (60.8%). MYLAN LABORATORIES LIMITED leads with a 37.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Valsartan export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Valsartan export data snapshot — $196.9M · 259 exporters · 119 countriesTransData Nexus · Indian Customs Data

Top Valsartan Exporters from India

259 active exporters · Ranked by export value

View all 259 →

Top Valsartan Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$73.0M	578	14	37.1%
2	MACLEODS PHARMACEUTICALS LTD

Top Countries Importing Valsartan from India

119 destination markets · Ranked by import value

All 119 countries →

Top Countries Importing Valsartan from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$119.8M	60.8%
2	GERMANY	$12.3M	6.2%
3	SLOVENIA	$9.6M	4.9%
4	HUNGARY	$7.1M	3.6%
5	IRAQ	$6.7M	3.4%
6	BELGIUM	$5.6M	2.8%
7	UNITED KINGDOM	$4.1M	2.1%
8	FRANCE	$4.0M	2.0%
9	CANADA	$3.3M	1.7%
10	PHILIPPINES	$2.2M	1.1%

UNITED STATES is India's largest valsartan export destination, absorbing 60.8% of total exports worth $119.8M. The top 5 importing countries — UNITED STATES, GERMANY, SLOVENIA, HUNGARY, IRAQ — together account for 78.9% of India's total valsartan export value. The remaining 114 destination countries collectively receive the other 21.1%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Valsartan to India?

33 origin countries · Total import value: $280.7B

India imports valsartan from 33 countries with a combined import value of $280.7B. The largest supplier is ITALY ($280.6B, 206 shipments), followed by BULGARIA and ISRAEL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Valsartan to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ITALY	$280.6B	206	100.0%
2	BULGARIA	$7.2M	60	0.0%
3	ISRAEL	$2.7M	8	0.0%
4	SWITZERLAND	$1.9M	31	0.0%
5	UNITED STATES	$1.9M	248	0.0%
6	CHINA	$265.5K	8	0.0%
7	SPAIN	$243.5K	19	0.0%
8	BRAZIL	$69.5K	39	0.0%
9	GERMANY	$57.2K	71	0.0%
10	NETHERLANDS	$39.8K	23	0.0%

Showing top 10 of 33 origin countries

ITALY is the largest supplier of valsartan to India, accounting for 100.0% of total import value. The top 5 origin countries — ITALY, BULGARIA, ISRAEL, SWITZERLAND, UNITED STATES — together supply 100.0% of India's valsartan imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Valsartan

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, valsartan is approved through Abbreviated New Drug Applications (ANDAs), as listed in the FDA's Orange Book. The FDA has granted numerous ANDAs for valsartan, indicating a competitive generic market. Notably, in March 2024, the FDA approved ANDA 213748 for Sacubitril and Valsartan Tablets, submitted by MSN Pharmaceuticals Inc., a U.S. agent for India's MSN Laboratories Private Limited. This approval underscores the active participation of Indian manufacturers in the U.S. pharmaceutical market.

The substantial number of Indian exporters (259) reflects a robust supply chain catering to the U.S. demand for valsartan. However, manufacturers must adhere to stringent FDA regulations, including compliance with Current Good Manufacturing Practices (cGMP) and prompt reporting of any adverse events or quality issues.

2EU & UK Regulatory Framework

In the European Union, valsartan-containing medicines require marketing authorization from the European Medicines Agency (EMA). For instance, Exforge, a combination of amlodipine and valsartan, received EU-wide approval on January 17, 2007. (ema.europa.eu) Similarly, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization of valsartan products within the UK.

Manufacturers exporting to the EU and UK must comply with Good Manufacturing Practice (GMP) standards, ensuring product quality and safety. Notably, in September 2018, an EU inspection found Zhejiang Huahai's site in China non-compliant with GMP in the manufacture of valsartan, leading to the suspension of its certificate of compliance. (ema.europa.eu) This incident highlights the critical importance of maintaining GMP compliance to avoid market disruptions.

3WHO Essential Medicines & Global Standards

Valsartan is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in global health. The WHO Prequalification Programme also evaluates valsartan products to ensure they meet international quality standards, facilitating their procurement by UN agencies and other organizations.

Pharmacopoeial standards for valsartan are established in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards is essential for market acceptance and regulatory approval across different regions.

4India Regulatory Classification

In India, valsartan is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including valsartan, to ensure affordability. Manufacturers intending to export valsartan must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with export regulations.

5Patent & Exclusivity Status

The primary patents for valsartan have expired, leading to increased generic competition globally. This has resulted in a more competitive market landscape, with multiple manufacturers producing and exporting valsartan, particularly from countries like India.

6Recent Industry Developments

In March 2024, the FDA approved ANDA 213748 for Sacubitril and Valsartan Tablets, submitted by MSN Pharmaceuticals Inc., highlighting the ongoing entry of Indian manufacturers into the U.S. market.

In September 2018, an EU inspection found Zhejiang Huahai's site in China non-compliant with GMP in the manufacture of valsartan, leading to the suspension of its certificate of compliance. (ema.europa.eu)

These developments underscore the dynamic nature of the valsartan market, influenced by regulatory actions, market approvals, and manufacturing compliance issues.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Valsartan

Retail & reference prices across 9 markets vs. India FOB export price of $8.45/unit

Global Price Benchmark for Valsartan across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA's Orange Book, Valsartan is approved for use in the United States.
United Kingdom	$0.40	GBP	As per the NHS Drug Tariff, Valsartan is listed for reimbursement.
Germany	$0.38	EUR	The European Medicines Agency (EMA) has authorized Valsartan for use within the European Union.
Australia	$0.45	AUD

Supply Chain Risk Assessment — Valsartan

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India is a leading producer of Active Pharmaceutical Ingredients (APIs), including valsartan. However, the production of these APIs is heavily reliant on Key Starting Materials (KSMs) sourced from China. According to the U.S. Pharmacopeia (USP), 41% of KSMs used in U.S.-approved APIs are solely sourced from China, while 16% are from India. This dependency poses a significant risk, as any disruption in the supply chain from China can directly impact API production in India.

The reliance on Chinese KSMs has previously led to quality concerns. In July 2018, the World Health Organization (WHO) reported the detection of N-nitrosodimethylamine (NDMA), a probable human carcinogen, in valsartan produced by Zhejiang Huahai Pharmaceuticals in China. This discovery prompted global recalls and highlighted the vulnerabilities associated with concentrated sourcing of critical raw materials. (who.int)

2Supplier Concentration & Single-Source Risk

The export market for valsartan from India is highly concentrated. Our proprietary trade data indicates that the top five exporters—Mylan Laboratories Limited, Macleods Pharmaceuticals Ltd, Sandoz Private Limited, Alembic Pharmaceuticals Limited, and Dr. Reddy's Laboratories Ltd—account for 75.5% of total exports. Notably, Mylan Laboratories Limited alone holds a 37.1% share. This concentration increases the risk of supply disruptions, as issues affecting a major supplier can have widespread implications.

Access Complete Valsartan Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 6,098 transactions across 119 markets.

Request Demo View Pricing

Frequently Asked Questions — Valsartan Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top valsartan exporters from India?

The leading valsartan exporters from India are MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, SANDOZ PRIVATE LIMITED, and 12 others. MYLAN LABORATORIES LIMITED leads with 37.1% market share ($73.0M). The top 5 suppliers together control 75.5% of total export value.

What is the total export value of valsartan from India?

The total export value of valsartan from India is $196.9M, recorded across 6,098 shipments from 259 active exporters to 119 countries. The average shipment value is $32.3K.

Which countries import valsartan from India?

India exports valsartan to 119 countries. The top importing countries are UNITED STATES (60.8%), GERMANY (6.2%), SLOVENIA (4.9%), HUNGARY (3.6%), IRAQ (3.4%), which together account for 78.9% of total export value.

What is the HS code for valsartan exports from India?

The primary HS code for valsartan exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Valsartan

Valsartan

Top Valsartan Exporters from India

Top Countries Importing Valsartan from India

Who Supplies Valsartan to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Valsartan

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Valsartan

Supply Chain Risk Assessment — Valsartan

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Valsartan Trade Intelligence

Frequently Asked Questions — Valsartan Exports from India

Who are the top valsartan exporters from India?

What is the total export value of valsartan from India?

Which countries import valsartan from India?

What is the HS code for valsartan exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of valsartan exports from India?

Which ports handle valsartan exports from India?

Why is India a leading exporter of valsartan?

What certifications do Indian valsartan exporters need?

How many buyers import valsartan from India?

What is the market share of the top valsartan exporter from India?

Analysis Methodology